Investment Rating - The investment rating for the company is "Outperform the Market" [5][20][21] Core Views - The company reported a significant year-on-year revenue increase of 54.65% for the first three quarters of 2025, reaching 9.49 billion, while the net profit attributable to shareholders grew by 28.56% to 1.96 billion [1][8] - The revenue for Q3 2025 was 4.03 billion, reflecting a year-on-year increase of 69.60% and a quarter-on-quarter increase of 31.38 [1][8] - The growth in revenue is attributed to the rapid development of domestic artificial intelligence and the increasing demand for high-end chips in the domestic market [1][8] - The company’s gross margin for Q3 2025 was 60.0%, down 9.1 percentage points year-on-year but up 0.7 percentage points quarter-on-quarter, primarily due to the increasing revenue share from lower-margin DCU products [2][18] - The company’s net profit margin for Q3 2025 was 29.78%, down 7.3 percentage points year-on-year and 0.5 percentage points quarter-on-quarter [2][18] Financial Performance - The company’s total prepayments and inventory as of Q3 2025 were 2.62 billion and 6.50 billion, respectively, indicating continuous growth and improved supply-side conditions [3][20] - Contract liabilities stood at 2.80 billion, maintaining a historical high, which reflects strong product demand [3][20] - The company forecasts revenues of 15.53 billion, 21.21 billion, and 25.60 billion for 2025, 2026, and 2027, respectively, with net profits expected to be 3.92 billion, 5.49 billion, and 6.39 billion for the same years [3][20][23] Valuation Metrics - The current price-to-earnings (P/E) ratios are projected to be 135, 97, and 83 for 2025, 2026, and 2027, respectively [3][20] - The company’s return on equity (ROE) is expected to reach 16.3%, 18.7%, and 17.9% for 2025, 2026, and 2027, respectively [4][23]

证券研究报告 | 2025年10月20日 25Q3 营收同比高增，归母净利润受少数股东损益扰动。公司发布 25Q3 财报， 2025 年前三季度实现营业收入 94.90 亿，同比+54.65%；归母净利润 19.61 亿元，同比+28.56%；扣非归母净利润 18.17 亿元，同比+23.18%。分季度来 看，25Q3 公司实现营业收入 40.26 亿元，同比+69.60%、环比+31.38%；归母 净利润 7.60 亿元，同比+13.04%、环比+9.26%；扣非归母净利润 7.27 亿元， 同比+10.56%、环比+12.17%。从收入端来看，受益于国内人工智能的快速发 展以及信创服务器 CPU 的自主可控，国内高端芯片市场需求持续增长，公司 通过深化与整机厂商、生态伙伴在重点行业、领域合作，加速在客户端的导 入，25Q3 营收实现同比高增。从利润端来看，25Q3 少数股东损益为 4.39 亿 元，同比+110%、环比+89%，大幅增长，进而导致公司归母净利润增速放缓。 毛利率、费用率同比下滑，环比提升。公司 25Q3 实现毛利率 60.0%，同比-9.1 个 pct、环比+0.7 个 pct，主要由于： ...

Core Insights - The company reported significant revenue growth in Q3 2025, with a year-on-year increase of 69.6% to reach 40.26 billion yuan, reflecting strong business expansion and positive trends in operations [1][2] - R&D expenses increased by 59.35% year-on-year in Q3, indicating a commitment to long-term growth potential despite a temporary decline in net profit margin [1][2] - The domestic AI application market is emerging as a new growth engine for "domestic computing power," with local models gaining traction and leading the global rankings [2] Financial Performance - For the first three quarters of 2025, the company achieved a revenue of 94.9 billion yuan, up 54.65% year-on-year, with a gross margin of 60.1% [1] - The net profit attributable to shareholders for the same period was 19.61 billion yuan, reflecting a year-on-year increase of 28.56% [1] - The Q3 single-quarter net profit margin was reported at 29.78%, down 7.34 percentage points year-on-year, primarily due to increased R&D investments [1][2] Product and Market Positioning - The company is one of the few domestic manufacturers capable of mass-producing x86 server CPUs and has developed GPGPU architecture for its DCU products, which are widely used in AI training and inference [3] - The company announced the opening of its CPU interconnect bus protocol (HSL) to collaborate with industry partners, aiming to build an efficient computing ecosystem [3] - The product matrix includes both CPU and DCU offerings, positioning the company favorably to meet the growing demand for AI computing power [3] Profit Forecast and Investment Rating - Based on the Q3 performance, the company slightly adjusted its net profit forecasts for 2025-2027 to 31.16 billion, 46.17 billion, and 65.29 billion yuan, respectively [4] - The investment rating remains at "Buy," reflecting confidence in the company's growth trajectory and market position [4]

Investment Rating - The investment rating for the company is "Outperform the Market" [5][18][21] Core Insights - The company reported steady growth in revenue and net profit, with a significant increase in contract liabilities, reinforcing confidence in annual performance [8][12] - The gross margin decreased due to a higher proportion of lower-margin DCU products, while the company continues to optimize its product matrix [2][14] - The architecture design is continuously upgraded, and the server ecosystem is steadily advancing, with collaborations with major domestic server manufacturers [3][17] Financial Performance - In H1 2025, the company achieved revenue of 5.464 billion, a year-on-year increase of 45.21%, and a net profit of 1.201 billion, up 40.78% [8] - For Q2 2025, revenue reached 3.064 billion, a year-on-year increase of 41.15%, and net profit was 696 million, up 23.14% [8] - The company’s gross margin for Q2 2025 was 59.3%, down 4.5 percentage points year-on-year, while the net profit margin was 30.3%, down 8.0 percentage points year-on-year [2][14] Future Projections - Revenue projections for 2025-2027 are 15.535 billion, 21.206 billion, and 25.595 billion respectively, with net profits expected to be 3.920 billion, 5.494 billion, and 6.385 billion [3][19] - The current stock price corresponds to a PE ratio of 81, 58, and 50 for the years 2025, 2026, and 2027 respectively [3][19]

Core Insights - The Sci-Tech Innovation Board (STAR Market) has evolved from a reform "testbed" to a highland for technological innovation, with a focus on six strategic emerging industries, achieving a total of 588 listed companies and a market capitalization exceeding 6.8 trillion yuan by June 2025 [1][2] Industry Overview - The STAR Market is particularly concentrated in the integrated circuit and pharmaceutical sectors, with 119 and 113 listed companies respectively, making it a major listing venue globally outside the US and Hong Kong [2] - The introduction of the "Eight Measures" has further stimulated resource allocation and industrial vitality in these sectors [2] Company Performance - Union Medical (688271.SH) raised 10.988 billion yuan during its IPO in August 2022, using the funds to enhance global expansion and production capacity for high-end medical imaging equipment [3] - The capital raised has significantly supported Union Medical in achieving breakthroughs in core technologies and establishing a complete self-research system for key components [3][4] - Aibo Medical (688050.SH) has experienced continuous revenue and net profit growth since its listing in 2020, with a compound annual growth rate of 39.56% in R&D investment from 2022 to 2024 [5][6] Market Dynamics - The STAR Market has become a key driver of domestic pharmaceutical innovation, with 33 globally new Class 1 drugs launched by STAR-listed companies since 2018, accounting for approximately 14% of all domestic Class 1 drugs approved during the same period [7] - In the integrated circuit sector, STAR-listed companies achieved a combined revenue of 72.182 billion yuan in Q1 2025, representing a 24% year-on-year increase, and a net profit of 4.479 billion yuan, up 73% [7][8] Strategic Developments - Companies like Longxin Zhongke (688047.SH) have accelerated their R&D iterations post-listing, increasing their annual new chip releases from 1-2 to 4-5 [8][9] - The ongoing push for domestic chip production is creating rapid development opportunities for chip companies, with significant growth in revenue and profitability observed [9][10] M&A Activity - The STAR Market encourages mergers and acquisitions as a means for companies to achieve external growth, with several notable cases emerging in 2023 [10][11] - Companies are actively seeking M&A opportunities to enhance their technological capabilities and market presence, with a focus on strategic alignment and operational synergy [11][12]

Core Viewpoint - This week, 70 stocks received significant attention from institutions, with a focus on the automotive and electronics sectors, particularly BYD and Haiguang Information [2][3][4]. Group 1: Institutional Ratings - A total of 58 institutions conducted 396 ratings, with 246 stocks receiving "buy" ratings [2]. - BYD received the highest attention with 19 ratings, followed by Haiguang Information with 10 ratings [2][5]. - The automotive sector, including stocks like Great Wall Motors and Yutong Bus, was the most favored [3]. Group 2: Sector Highlights - The electronics sector, featuring stocks such as Haiguang Information and Hengrui Technology, was the second most focused area with 7 stocks receiving attention [4]. - The semiconductor industry is projected to see significant growth, with global sales expected to reach $617.3 billion in 2024, a 19.1% increase [12]. Group 3: Company Performance - BYD's global sales are projected to reach 4.27 million units in 2024, ranking fourth in global automotive sales, with a 161.39% year-on-year increase in February 2025 [8]. - Haiguang Information is expected to achieve over 50% revenue and profit growth in 2024, with a three-year compound annual growth rate of 58.29% [13]. - Hengrui Technology reported a 49.94% increase in revenue for 2024, while Bawei Storage achieved an 86.71% revenue growth [14]. Group 4: Investment Recommendations - Institutions have raised ratings for Haiguang Information and Keri International, with Haiguang Information's target market value adjusted to 426.2 billion yuan [15]. - 21 stocks have over 30% upside potential based on institutional target prices, with Yinghe Technology showing over 120% upside potential [16].

Investment Rating - The investment rating for the company is "Buy" [5][12]. Core Views - The company achieved significant revenue growth in 2024, with total revenue reaching 9.162 billion, a year-on-year increase of 52%, and a net profit attributable to shareholders of 1.931 billion, up 53% [1][5]. - The company has proactively increased strategic inventory to meet downstream demand, ending 2024 with inventory valued at 5.425 billion, a 405% increase year-on-year [1]. - The company is heavily investing in research and development, with R&D expenses amounting to 2.910 billion in 2024, a 46% increase from the previous year [1][2]. Financial Summary - In 2024, the company reported revenue of 91.62 billion, with a growth rate of 52.4% compared to 2023 [3]. - The net profit for 2024 was 19.31 billion, reflecting a growth rate of 52.9% [3]. - The company expects revenue to grow to 132.78 billion, 179.19 billion, and 232.87 billion in 2025, 2026, and 2027, respectively, with growth rates of 45%, 35%, and 30% [2][3].